News from imaginab, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 28, 2014, 08:00 ET

ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development

 ImaginAb, Inc. today announced today announced that it has appointed Roger Crystal, MD as Vice President of Business Development. Dr. Crystal...

Jun 10, 2014, 16:00 ET

NCM and ImaginAb Ink Clinical Isotope Supply and Labeling Agreement

NCM USA announced today it has signed a long-term clinical zirconium isotope (89Zr) supply and cGMP biologics labeling agreement with ImaginAb,...

Jun 09, 2014, 08:00 ET

ImaginAb Partners with IBA Molecular for Clinical Supply of 89Zr Labeled Drug Product

 ImaginAb, Inc. (ImaginAb) and IBA Molecular North America, Inc. (IBA Molecular) announced that IBA Molecular has been selected to...

Jun 06, 2014, 08:00 ET

ImaginAb Presents Initial Phase I/IIa Results for Prostate Imaging Agent at Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

 ImaginAb, Inc., in collaboration with Memorial Sloan-Kettering Cancer Center (MKSCC), will be presenting initial clinical data with an...

Jun 03, 2014, 09:56 ET

ImaginAb Enters into Exclusive Licensing Agreement with UCLA for Immune Cell Imaging Agents

 ImaginAb, Inc. and the Regents of the University of California, Los Angeles (UCLA) have executed a technology licensing agreement relating to...

May 21, 2014, 11:22 ET

ImaginAb Launches Japanese Subsidiary

ImaginAb, Inc. announced today the formal launch of ImaginAb Japan KK, a wholly-owned subsidiary of Los Angeles-based ImaginAb, Inc....

May 08, 2014, 14:50 ET

ImaginAb Concludes $21 Million Series B Financing

 ImaginAb, Inc., a clinical stage biotechnology company that engineers antibodies into smaller protein formats optimized for in vivo molecular...

Feb 10, 2014, 09:00 ET

ImaginAb and Duke-NUS Launch Imaging Biomarker Development Lab (IBDL)

 ImaginAb, Inc. today announced that it has entered into a partnership with the Duke-NUS Graduate Medical School Singapore...

Nov 25, 2013, 14:15 ET

ImaginAb Expands Scientific Advisory Board

ImaginAb, Inc., a clinical-stage company developing in vivo molecular imaging agents based on antibody fragment technology, today announced that it...

Apr 01, 2013, 08:30 ET

Emerging Precision Medicine Powerhouse Changes Name to Increase Visibility and Overall Awesomeness

ImaginAb, Inc., a clinical-stage company developing in vivo molecular imaging agents based on antibody technology, today announced that it has...

Oct 08, 2012, 08:00 ET

ImaginAb and Lundbeck to Collaborate in Neurodegeneration

ImaginAb, Inc., a clinical-stage company developing in vivo molecular imaging agents based on antibody fragment technology, today announced that it...

Sep 05, 2012, 07:30 ET

ImaginAb and MacroGenics Collaborate to Develop In Vivo Imaging Agents for Autoimmune Diseases, Cancer

 ImaginAb, Inc. a developer of in vivo molecular imaging agents based on its proprietary antibody fragment platform, today announced that it...

Aug 13, 2012, 08:30 ET

Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman

ImaginAb, Inc. a developer of in vivo molecular imaging agents based on its proprietary antibody fragment platform, today announced that Abbie...

Aug 07, 2012, 08:30 ET

ImaginAb and Singapore Radiopharmaceuticals Sign Master Service Agreement

 ImaginAb, Inc. a developer of in vivo molecular imaging agents based on its proprietary antibody fragment platform, today announced that it...

Mar 26, 2012, 23:29 ET

ImaginAb Concludes $12.5m Series A Financing

ImaginAb, Inc. a clinical-stage company developing in vivo imaging agents for Positron Emission Tomography (PET) based on antibody fragment...

Oct 31, 2011, 13:50 ET

ImaginAb, Inc. Awarded $2.3 Million from the National Cancer Institute

ImaginAb, Inc. is pleased to announce that it has been awarded a total of $2.3 million in funding from the National Cancer Institute's (NCI) Small...

Sep 06, 2011, 14:05 ET

ImaginAb, Inc. Announces Formation of Singapore Subsidiary, ImaginAb Molecular Imaging Pte Ltd.

ImaginAb, Inc. is pleased to announce the establishment of a wholly owned Singapore-based subsidiary, ImaginAb Molecular Imaging Pte Ltd (IMI). IMI...

Jun 07, 2011, 08:00 ET

ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging

ImaginAb, Inc. is pleased to announce the availability of custom radiolabeling services for proteins, peptides and other macromolecules as of the...

Jun 06, 2011, 12:53 ET

Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb

Oxford BioMedicaplc ("Oxford BioMedica" or "the Company") (LSE: OXB), a leading gene therapy company, today announces that it has signed a research...

Jun 06, 2011, 08:30 ET

ImaginAb, Inc. to Join "KeyMarker" Consortium to Develop Next-Generation Diagnostics for Diabetes

ImaginAb, Inc. has been invited to join KeyMarker, a leading consortium of Belgian academic scientists and biotech companies for the discovery of...